DAMORA THERAPEUTICS, INC.

DMRA ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
4	Aug 13, 2026	4
3	Aug 13, 2026	3
EFFECT	Aug 12, 2026
S-8 POS	Aug 10, 2026	S-8 POS
S-8 POS	Aug 10, 2026	S-8 POS
POSASR	Aug 10, 2026	POSASR
S-8 POS	Aug 10, 2026	S-8 POS
S-8 POS	Aug 10, 2026	S-8 POS
S-8 POS	Aug 10, 2026	S-8 POS
S-8 POS	Aug 10, 2026	S-8 POS
S-8 POS	Aug 10, 2026	S-8 POS
S-8 POS	Aug 10, 2026	S-8 POS
POS AM	Aug 10, 2026	POS AM
8-A12B/A	Aug 10, 2026	8-A12B/A
10-Q	Aug 10, 2026	10-Q
144	Aug 6, 2026
SCHEDULE 13G	Jul 28, 2026
8-K	Jul 20, 2026	8-K
4	Jul 7, 2026	4
144	Jun 22, 2026
8-K	Jun 17, 2026	8-K
SCHEDULE 13G/A	May 15, 2026
SCHEDULE 13G/A	May 15, 2026
SCHEDULE 13G	May 15, 2026
10-Q	May 12, 2026	10-Q

← Newer Page 1 of 15 · 351 filings Older →